<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02614924</url>
  </required_header>
  <id_info>
    <org_study_id>RD098211</org_study_id>
    <nct_id>NCT02614924</nct_id>
  </id_info>
  <brief_title>Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation</brief_title>
  <official_title>Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Coventry and Warwickshire NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Coventry and Warwickshire NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify whether Pentax Airway Scope (AWS) videolaryngoscope&#xD;
      would be a more effective device compared to flexible fibreoptic scope (FOS) for awake&#xD;
      intubation in a difficult airway.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      The incidence of difficult tracheal intubation during routine anaesthesia in general&#xD;
      population is around 3-18% although it varies [1]. Awake intubation is considered in&#xD;
      situations such as in patients with a known or suspected difficult airway, upper airway&#xD;
      obstruction. Awake intubation under local anaesthesia and sedation also indicated cervical&#xD;
      spine disease in view of minimising movement of cervical spine [2]. Any technique tracheal&#xD;
      intubation under general anaesthesia involves some degree of movement at cervical spine.&#xD;
      Direct laryngoscopy and tracheal intubation in under general anaesthesia is usually achieved&#xD;
      by flexion of lower cervical spine and extension at atlanto-occipital joint [3]. Difficulties&#xD;
      or failure in airway management is still an important factor in morbidity and mortality&#xD;
      related to anaesthesia.&#xD;
&#xD;
      In recent years videolaryngoscopes have been used as an alternative to traditional fibreoptic&#xD;
      scope in the management of difficult airway [4,7,8]. Over last 2 years in our institution the&#xD;
      investigators have used Pentax AWS videolaryngoscope for awake intubation in patients&#xD;
      presenting for surgery with cervical spine disease [9, 10].&#xD;
&#xD;
      However there has not been any study comparing flexible fibreoptic scope with video&#xD;
      laryngoscopes in the management of difficult airway in awake patients. The proposed benefits&#xD;
      of Pentax AWS (Airway scope) over a flexible fibreoptic scope include ease of setting up the&#xD;
      device, less complexity of the skill, therefore easy to learn the skill and availability of&#xD;
      disposable devices minimising the need for cleaning and disinfecting the device.&#xD;
&#xD;
      Pentax AWS with PBlade videolaryngoscope has a unique target symbol displayed on the monitor,&#xD;
      which highlights the intended path of the endotracheal tube. The Pentax PBlade is a single&#xD;
      patient use device that minimizes the risk of infection.&#xD;
&#xD;
      Study Design and Methods: Randomised Controlled Trial&#xD;
&#xD;
      Patient Selection:&#xD;
&#xD;
      Forty patients presenting for cervical spine surgery under general anaesthesia and requiring&#xD;
      oral endotracheal intubation will be invited to take part in the study. During preoperative&#xD;
      visit, a patient information sheet will be given to the patients meeting the eligible&#xD;
      criteria. The patient will be given adequate time to read the information sheet and any&#xD;
      queries will be answered. Wherever possible, suitable patients will be identified in the&#xD;
      preoperative assessment clinic. A detailed airway assessment will be performed by one of the&#xD;
      investigator.&#xD;
&#xD;
      Whenever possible, when patients are admitted the night before their operation, they should&#xD;
      be seen by an Anaesthetist and given the study information.&#xD;
&#xD;
      Techniques of Anaesthesia:&#xD;
&#xD;
      After securing intravenous cannulation and instituting standard anaesthetic monitoring with&#xD;
      ECG, pulse oximetry and non-invasive blood pressure monitoring, conscious sedation will be&#xD;
      started using target controlled infusion of remifentanil and 1 mg of midazolam. At this stage&#xD;
      numbered opaque envelope will be opened to choose one of the two devices. The tongue,&#xD;
      oropharynx and larynx will be anaesthetised using 4% lignocaine using Mckenzie technique&#xD;
      (nebulisation of local anaesthetic through 20 G cannula).&#xD;
&#xD;
      Adequate anaesthesia of upper airway will be checked by inserting an appropriately sized&#xD;
      oropharyngeal airway (if the patient can tolerate well, the airway is anesthetised&#xD;
      adequately, if not further local anaesthetic is administered to the oropharynx). After&#xD;
      confirming adequate anaesthesia of upper airway, the chosen device will be inserted into the&#xD;
      oropharynx. Further local anaesthesia to the base of the tongue, larynx and trachea will be&#xD;
      administered using spray as you go technique where the local anaesthetic administered through&#xD;
      the device whilst gradually advancing the device towards larynx. After confirming the&#xD;
      position of the tracheal tube and testing the gross neurological state of all 4 limbs,&#xD;
      general anaesthesia will be induced.&#xD;
&#xD;
      Data Collection:&#xD;
&#xD;
      During the procedure of laryngoscopy and endotracheal intubation, a modified intubation&#xD;
      difficulty score (IDS) would be developed based on the parameter recorded. Along with&#xD;
      intubation difficulty score other parameters compared include: time taken to complete the&#xD;
      process of intubation, anaesthetist rating of intubation and patient rating of procedure.&#xD;
&#xD;
      The following parameter would be recorded and scored:&#xD;
&#xD;
        1. Coughing episode: 0 no cough 1 if mild cough, 2 if moderate cough, 3 if severe cough.&#xD;
&#xD;
        2. Gagging episode: 0 no gagging, 1 if mild gag, 2 if moderate gag, 3 if severe gag.&#xD;
&#xD;
        3. Ease of insertion of device: 0 easy, 1 if mild difficulty 2 if moderately difficulty, 3&#xD;
           very difficult.&#xD;
&#xD;
        4. Laryngoscope view based on the percentage of the glottis visualised 0 if 75-100% view, 1&#xD;
           if 50-75% view, 2 if &lt;50% view, 3 no VC visible.&#xD;
&#xD;
        5. Tube rotation or manipulation, 0 if no rotation required, 1 if rotation required&#xD;
&#xD;
        6. Airway trauma, 0 no trauma, 1 if minor injury (lip), 2 if oro-pharyngeal injury/&#xD;
           bleeding. 3, bleeding requiring use of suction&#xD;
&#xD;
        7. Stress response based on heart rate and blood pressure (0 if stable, 1 if increased more&#xD;
           than 20%)&#xD;
&#xD;
        8. Overall patients' tolerance as judged by the Anaesthetists (visual analogue score of 0&#xD;
           to 100mm)&#xD;
&#xD;
        9. Overall impression from patient on a visual analogue scale (visual analogue score of 0&#xD;
           to 100mm)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Time Taken to Complete the Procedure of Awake Intubation</measure>
    <time_frame>up to 20 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation Time</measure>
    <time_frame>up to 10 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Anesthesia Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Flexible fibre-optic scope</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Randomly allocated to fibreoptic group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pentax AWS videolaryngoscope</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Randomly allocated Pentax AWS videolaryngoscope</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flexible fibreoptic scope</intervention_name>
    <description>Patient intubated using fibreoptic scope</description>
    <arm_group_label>Flexible fibre-optic scope</arm_group_label>
    <arm_group_label>Pentax AWS videolaryngoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pentax AWS videolaryngoscope</intervention_name>
    <description>Patient intubated using Pentax AWS videolaryngoscope</description>
    <arm_group_label>Flexible fibre-optic scope</arm_group_label>
    <arm_group_label>Pentax AWS videolaryngoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with cervical spine disease presenting for cervical spinal surgery and&#xD;
             requiring awake intubation under local anaesthesia and conscious sedation.&#xD;
&#xD;
          -  Patients with anticipated difficult airway include those with Mallampati class 3 and&#xD;
             above, other signs such as limited neck movement and limited jaw protrusion will be&#xD;
             include in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children below 18 years of age, pregnant mothers and patients presenting with airway&#xD;
             pathology will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>November 24, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2015</study_first_posted>
  <results_first_submitted>March 16, 2016</results_first_submitted>
  <results_first_submitted_qc>July 12, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 22, 2016</results_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited between 27.11.12 till 24.7.14. Recruitment was done during anaesthetic prep assessment.</recruitment_details>
      <pre_assignment_details>No participants were excluded</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Flexible Fibre-optic Scope</title>
          <description>Randomly allocated to fibreoptic group&#xD;
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
        </group>
        <group group_id="P2">
          <title>Pentax AWS Videolaryngoscope</title>
          <description>Randomly allocated to Pentax AWS</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Flexible Fibre-optic Scope</title>
          <description>Randomly allocated to fibreoptic group&#xD;
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
        </group>
        <group group_id="B2">
          <title>Pentax AWS Videolaryngoscope Group</title>
          <description>Randomly allocated Pentax AWS videolaryngoscope and intubated using Pentax AWS videolaryngoscope</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.5" lower_limit="23" upper_limit="77"/>
                    <measurement group_id="B2" value="66.5" lower_limit="44" upper_limit="77"/>
                    <measurement group_id="B3" value="60.5" lower_limit="23" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Time Taken to Complete the Procedure of Awake Intubation</title>
        <time_frame>up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flexible Fibre-optic Scope</title>
            <description>Randomly allocated to fibreoptic group&#xD;
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
          </group>
          <group group_id="O2">
            <title>Pentax AWS Videolaryngoscope</title>
            <description>randomly allocated to Pentax AWs</description>
          </group>
        </group_list>
        <measure>
          <title>Total Time Taken to Complete the Procedure of Awake Intubation</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="900" lower_limit="739" upper_limit="1059"/>
                    <measurement group_id="O2" value="651" lower_limit="601" upper_limit="720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intubation Time</title>
        <time_frame>up to 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flexible Fibre-optic Scope</title>
            <description>Randomly allocated to fibreoptic group&#xD;
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
          </group>
          <group group_id="O2">
            <title>Pentax AWS Videolaryngoscope</title>
            <description>Randomly allocated to Pentax AWS</description>
          </group>
        </group_list>
        <measure>
          <title>Intubation Time</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420" lower_limit="283" upper_limit="480"/>
                    <measurement group_id="O2" value="183" lower_limit="144" upper_limit="220"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>20 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Flexible Fibre-optic Scope</title>
          <description>Randomly allocated to fibreoptic group&#xD;
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
        </group>
        <group group_id="E2">
          <title>Pentax AWS Videolaryngoscope</title>
          <description>Randomly allocated to Pentax AWS group Pentax AWS videolaryngoscope group: Patient intubated with Pentax AWS</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Ratidzo Danha</name_or_title>
      <organization>UHCW NHS Trust</organization>
      <phone>02476 964000 ext 25871</phone>
      <email>Ratidzo.Danha@uhcw.nhs.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

